devinitorg/iati-policy-markers huggingface dataset:
Core funding to Misean Cara, which provides grants to missionary organisations for their development work in Africa, Asia and South America Improving Health Access and Outcomes for the poor,Marginalised ,hard  to reach people of Mutito in Kitui East ,Kitui County, Kenya - with a focus on reproductive health care implemented by Poor Servants of the Mother of God P04/MED/0621/02/2021-3yr
Support to COP for 2022 International Women's Programme Quality, Support and Devt Support to COP for 2022 International Women's Day Celeberation Inspiration Lifeline
PERFORMANCE-BASED PARTNERSHIP SCHEME FOCUSING ON QUALITY PROGRAMMING, UNDERSTANDING  CHANGE AND  RESULTS FOR POOR HOUSEHOLDS AND COMMUNITIES Increased understanding and support for Ireland's development programme Increased understanding and support for Ireland's development programme The Irish public have increased understanding of and support for the important role local communities play in responding to humanitarian crises.
PERFORMANCE-BASED PARTNERSHIP SCHEME FOCUSING ON QUALITY PROGRAMMING, UNDERSTANDING  CHANGE AND  RESULTS FOR POOR HOUSEHOLDS AND COMMUNITIES Women and Men in situations of poverty and/or vulnerability enjoy the respect of their civil, political, economic, social, cultural and environmental rights in Honduras Outcome 3.2: Honduran women live free of violence Objective 1: Duty-bearers take significant actions against impunity for violence and crimes against women through the promotion of an enabling environment
Core funding to Misean Cara, which provides grants to missionary organisations for their development work in Africa, Asia and South America Education: Provision of basic life skills and education support for learners with disabilities, Rwentobo, Ntungamo District, Kabale, Uganda implemented by Viatores Christi V01/MED/0822/07/2022-3yr
INDEPENDENT WATCHDOG FOR THE GLOBAL FUND CORE FUNDING Aidspan is a watchdog organization that’s mission is to highlight, analyse and influence the transparency and effectiveness of the Global Fund to Fight AIDS, Tuberculosis and Malaria at the global and country level. AIDSPAN provides information, analysis and advice; facilitating critical debate; and promoting greater transparency, accountability, effectiveness and impact. Aidspan’s work focuses on promoting value for money and increasing transparency and accountability within the Fund and at country level.
Core funding to Misean Cara, which provides grants to missionary organisations for their development work in Africa, Asia and South America Security and dialogue for peace during elections with additional provision of material assistance and medical services and medication for long term chronic illnesses implemented by Medical Missionaries of Mary M04/EME/0122/04/2022-1yr
Intervention for conflict Affected IDP HHs Intervention for conflict Affected IDP HHs
PERFORMANCE-BASED PARTNERSHIP SCHEME FOCUSING ON QUALITY PROGRAMMING, UNDERSTANDING  CHANGE AND  RESULTS FOR POOR HOUSEHOLDS AND COMMUNITIES Long Term Outcome Eritrea: Rural HHs and communities with greater food and energy security and improved  health through enhanced resilience capacity Intermediate Outcome 1:Sustained Improvement in Agricultural Production and additional Incomes for Smallholder Farmers
Achieve SDGs-Emphasis on furthest behind first EXPANDING SOCIAL PROTECTION PROGRAMME Outcome 1: Work to achieve the SDGs with an emphasis on the furthest behind first Ireland supports the Expanding Social Protection Programme, which allows senior citizens to benefit from regular, predicable social assistance grants for empowerment (SAGE), and supports shock-responsive programming activities.
DFA-Science Foundation Ireland SDG Challenge 2022 DFA-Science Foundation Ireland SDG Challenge 2022
2022 UNDP CONTRIBUTION IRELAND Voluntary core contribution to UNDP to support their strategic objectives which cover: poverty reduction, governance; crisis prevention and increased resilience; environment; clean, affordable energy; and gender equality.
GCRF: South Asia Self Harm research capability building initiative (SASHI) UKRI GROW award - The SASHI project will focus on selfharm and suicide in India and Pakistan, equipping local researchers with skills to develop longterm programmes to reduce death, disability and distress. The project will set up deliberate selfharm registers; conduct hou The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
How do local participatory governance reforms influence equitable access to health services? The role of Panchayati Raj Institutions in Kerala, India Joint HSR Initiative 1 Dev award  to explore how local participatory governance (LPG) reforms influence equitable access to health services in India The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
Making health financing work for the poor: An evaluation of equity in health systems financing in Indonesia JHSR 3 Full 2016 award looking at an evaluation of equity in health system financing in Indonesia The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
How do human and bacterial behaviour interact in urban and rural African environments to facilitate the stable acquisition of antimicrobial resistance The development of antibacterials has saved millions of lives; however, the massive global usage of these agents has created huge pressure for bacteria to become resistant to these drugs and to cause infections that are difficult or impossible to treat. This, combined with the flow of drugs slowing profoundly, has made antibiotic resistance a threat to health of global importance. New approaches are necessary to reduce illness caused by resistant bacteria.  In Low and Middle Income countries (LMIC), there is a huge burden of severe illness caused by bacteria, a critical lack of clinics and hospitals to diagnose and appropriately treat bacterial infections and widespread availability of antibiotics without prescription. This situation is responsible for a huge amount of illness and is increasing the pressure on bacteria to become drug resistant. LMIC settings will be the last to benefit from new types of antibiotics and it is therefore of urgent importance to undertake research addressing antibiotic resistance in LMICs that aims to identify which are the most important causes or drivers of the development of drug resistance. This requires scientists from a variety of fields and with a variety skills, from the laboratory to policy implementation to work together.   We will therefore describe both where bacteria live when not causing infections, whether in humans, animals or the environment, and how antimicrobials are used and misused in humans animals and the environment to:    1. Determine ways of using antibiotics make resistance come at a cost rather than as a benefit to bacteria 2. Develop ways of using antibiotics across all sectors that both improves access for people that really need them, but protects medicines of last resort in a manner acceptable to governments, communities and doctors to minimise the local emergence  of resistance; 3. Identify ways in which different parts of government, the health and research sectors can more effectively work together to reduce antibiotic resistance at national and district level, both within and between human and animal health and the environment. The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
Preventing cervical cancer in older Vietnamese women Cervical cancer is a leading cause of cancer mortality in Vietnam with over 80% of deaths among women aged over 45 years.  In Western countries, regular cervical screening allows cancers to be detected and treated, but cervical screening in Vietnam is rare and less than 5% of the population have ever been screened. This means that cancers are detected later and are often fatal.   Human papillomavirus (HPV) causes cervical cancer and is common in younger people in Vietnam. Research into how best introduce a vaccine to prevent future cervical cancers is currently being undertaken. However, little is being done to help women who are too old to be vaccinated and are now at highest risk of developing cancer. We propose to strengthen existing research partnerships between LSHTM and both the Pasteur Institute and Cancer Registry in Ho Chi Minh City (HCMC) in order to pilot an innovative HPV screening method among older Vietnamese women.  Our research in the UK has indicated that the majority of invasive cancers could have been detected by sensitive HPV testing compared to very few by cytology (a smear test). This project will pilot HPV testing in two districts of HCMC in 300 women aged 45-64 years. The women testing positive will be invited for repeat testing after 1 year and those still positive will be invited to undergo a therapeutic biopsy with the aim of greatly reducing their future cancer risk. In addition, 100 former sex workers will be identified and also invited to take part. These women are estimated to be at much higher risk of developing cervical cancer than the general population and therefore are an important target group for HPV screening. This pilot project will allow us to assess the response rate and also the attitudes to screening in those that accept their screening invite compared to those who refuse.  The cancer registry in HCMC is well organised but poorly resourced. Analysis of the data is required to understand unexpected changes in cancer rates which are likely to be due to migration in and out of the city. At least 50 cervical cancer patients identified by the registry will be interviewed in this pilot study to between understand their characteristics including whether they have moved from a rural area to HCMC. The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
Public Health Initiative on LMIC Air Pollution (PHILAP) The PHILAP proposal brings together a multidisciplinary team with a range of expertise to bear on the problem of health effects of air pollution in Delhi, India which is not only a critical case but also a microcosm of a wider global health concern in low and middle income countries, tied up with questions of social justice and equity. In particular, PHILAP seeks to characterise the burden of asthma in adolescents living in the slums of Delhi - a marginalised section of the population who have dropped out of the school system and are engaged in ad-hoc work in the informal sector. PHILAP will employ state-of-the-art miniature wearable sensors currently deployed in Delhi in the MRC-/NERC-funded (2016-21) DAPHNE (Delhi Air Pollution: Health and Effects) as part of the Air Pollution and Human Health (APHH) - Delhi programme, to measure actual personal exposure to particulate pollution and contemporaneously recording its physiological effects, such as changes in the respiratory rate/flow and physical activity levels, with the aim of correlating disease control of asthma with air pollution exposure. These measurements will be situated, and made sense of, in the social and cultural contexts of people's everyday lives through ethnographic fieldwork and interviews. By engaging the ethnographic data in dialogue with the scientific data of urban air pollution and exposure and its clinical effects, we hope to unpick the multiple strands in the entwined health dimensions of breathing and living with air pollution. PHILAP will harness these vast data-sets, produced and mobilised across the work-packages, into a series of public facing visual narratives that seek to foster dialogue at the interface of science, arts and humanities research. The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
MRC Gambia Unit fund to set up test facilities, increase clinical service capacity, engaging with the community in The Gambia to test for COVID-19 MRC GCRF Award -Testing for COVID-19 on behalf of the Gambia Government, set up testing facilities in our labs in Basse and Keneba, double Clinical Services Capacity in Fajara and Keneba, Provision of PPE, Community Sensitization and community engagement. COVID-19 The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
ODA Programmes within MRC Centre for Virus Research The mission of the Centre for Virus Research is to carry out fundamental research on viruses and viral diseases, translating the knowledge gained for the improvement of health and benefit of society to multiple Lower and middle income countries The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
Evaluation of a novel microbiological diagnostic test for latent tuberculosis infection in Ethiopia (Micro-LTBI) GCRF Foundation Infections 2016 evaluating a novel microbiological test for latent tuberculosis (TB) infection in Ethiopia – with the potential benefit to, participants, capacity building research staff and participating institutions The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
Multimorbidity in Africa - Increasing Understanding of the Patient Experience and Epidemiology (MAfricaEE) GCRF Global Multiorbidity award to establish a comparative account of multimorbidity in three sub-Saharan African countries which characterises prevalence, patterns and patient experiences. The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
Identifying the drivers and vulnerabilities of acral lentiginous melanoma through the study of PDX models from Latin American patients Melanoma is the common cancer that has increased its worldwide incidence the most in the last decades. Survival rates for cutaneous melanoma have increased dramatically in the last decades due in part to the development of drugs that specifically target disease subtypes and agents that stimulate the immune response against tumours. These breakthroughs have been possible thanks to the study of mutations in melanoma genomes and the use of pre-clinical models that faithfully resemble human tumours. However, this success has not been realised yet for patients with acral lentiginous melanoma (ALM), which constitutes the most common subtype of this disease in some Latin American countries. ALM has remained poorly studied to date due to its rarity in European-descent populations, and its causes and genetic and environmental drivers remain mostly unknown; thus survival rates and response to therapy are still poor in these patients. The long-term aim of this project is to develop novel therapies for ALM patients. In this context, we have two specific aims:   1. Generate and characterise a comprehensive collection of faithful ALM pre-clinical models in the form of patient-derived xenografts (PDX). PDX are human tumours implanted into immunodeficient mice. This collection will include tumours from a variety of body locations and will come from Brazil and Mexico to account for the large variability observed within the disease. We will sequence each PDX's protein-coding genome, and determine gene and protein expression levels to understand what biological pathways are altered in ALM tumours. We will also analyse genetic ancestry, which has been hypothesised to increase risk to develop some tumour types, such as breast cancer. An enrichment of certain genome variants in cases when compared to their population of origin might indicate regions of the genome that modify risk to develop ALM.   2. Use the PDX collection in order to explore new targets for therapy and biomarkers of ALM. The molecular characterisation of ALMs will allow us to identify potential drug targets, biomarkers useful to determine responders to a specific treatment, and potential resistance mechanisms. We plan to explore this at first by focusing on CDK4 pathway dependencies via direct treatment of PDX-carrying mice with CDK4 inhibitors followed by assessment of tumour growth, as well as the study of gene and protein profiles of responder and non-responders.   We expect that the results from this project will identify genetic risk factors and suggest therapeutic alternatives for ALM patients, and that it will establish a valuable resource, in the form of a PDX collection, that can be shared with the research community. The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
A systems approach to examining health sector responses to cholera epidemics in Kenya Simple Summary  Kenya has experienced an increased disease burden due to cholera outbreaks characterized by continuous transmission in the refugee camp settings of Garissa and Turkana, and sporadic transmission in cities such as Nairobi and Mombasa. However, while inquiry has been made regarding how the health sector has responded to and how populations have been impacted by epidemics such as cholera, not enough attention has been paid to causal relationships between the unique components of the health systems leading to an inadequate understanding of how the building blocks of the health systems interact in disease surveillance and epidemic response. Consequently, this research effort focuses on examining the health sector responses to these epidemics, developing a systems-theory-based description of the said responses, and based on the results, provide recommendations that may help break the epidemic's continuous and cyclical nature.  The study will be conducted in Turkana and Garissa in Kenya, as well as in Nairobi. These are counties that have diverse levels of health system sophistication and recent experiences of cholera epidemics. Moreover, the study draws on several systems analytic frameworks to determine the actors and their decisions, as well as their inter-relationships, linkages and dependencies. Thus, the study appropriates systems-oriented research techniques and applies them in a novel fashion to the assessment of health service delivery. The findings of this study are expected to guide interventions aimed at improving disease surveillance and epidemic response. The study will also act as a primer for the research community by assessing the utility of systems-thinking approaches in such settings, and subsequently opening a related research agenda. The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
The role of improved housing in the African malaria recession Social Science Interface 2015 - RM 2016 award to  evaluate the potential of building better homes to have an impact on Malaria in Africa The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
Tracking Haulage in East Africa to support COVID-19 surveillance- THEA-C19 MRC GECO COVID award to develop and test digital contact tracing technology tailored to the haulage industry within Uganda
 COVID-19 The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.
MICA: BRAINTOOLS Phase 1: Optimising neurodevelopmental outcomes for global health Global Mental Health Institutional pump priming awards first stage to optimise neurodevelopmental outcomes for global health working with Gambia The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.